Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB

被引：0
|
作者：
Kimerling, ME
Kluge, H
Vezhnina, N
Iacovazzi, T
Demeulenaere, T
Portaels, F
Matthys, F
机构：
[1] Univ Alabama, Sch Med, Dept Med, Birmingham, AL USA
[2] Med Sans Frontieres, Brussels, Belgium
[3] Colony 33 Med Dept, Mariinsk, Russia
[4] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 1999年 / 3卷 / 05期
关键词：
tuberculosis; multidrug resistance; prisons;
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Multidrug-resistant tuberculosis (MDR-TB) threatens the progress of global control efforts. Prisons represent a high risk setting for development and transmission of MDR-TB. In a Siberian TB referral prison (Kemerovo region), the treatment failure rate is 35% (June 1996-March 1997), despite implementation of a strict DOTS program and use of the World Health Organization Category 2 re-treatment regimen for all new cases. Among 164 patients (December 1997-March 1998), initial resistance to isoniazid and rifampin is 22.6%. Such a rate is a warning call to reconsider prison control strategies, and importantly, to address the treatment regimens necessary to combat an institutional epidemic of MDR-TB.
引用
收藏
页码：451 / 453
页数：3
相关论文
共 39 条
  • [21] THE INCIDENCE OF MULTI DRUG RESISTANT TUBERCULOSIS AMONG PATIENTS RECEIVING STANDARDIZED TREATMENT REGIMEN FOR SUSPECTED MDR-TB
    Sablan, Augusto J. R.
    Gonong, Joven R.
    Balanag, Vincent B.
    Raymond, Lawrence S.
    RESPIROLOGY, 2013, 18 : 10 - 10
  • [22] Drug resistance among failure and relapse cases of tuberculosis:: is the standard re-treatment regimen adequate?
    Quy, HTW
    Lan, NTN
    Borgdorff, MW
    Grosset, J
    Linh, PD
    Tung, LB
    van Soolingen, D
    Raviglione, M
    Cô, NC
    Broekmans, J
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (07) : 631 - 636
  • [23] Short 12-month regimen with intravenouse linezolid for MDR-TB: treatment outcomes and first follow up results.
    Lytvynenko, Nataliia
    Varytska, Hanna
    Pogrebna, Maryna
    Senko, Yulia
    Chobotar, Oksana
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [24] Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study
    Hassane-Harouna, Souleymane
    Cherif, Gba-Foromo
    Ortuno-Gutierrez, Nimer
    Cisse, Diao
    Camara, Lansana Mady
    Diallo, Boubacar Djelo
    Camara, Souleymane
    Bangoura, Adama Marie
    Lynen, Lutgarde
    Decroe, Tom
    PLOS ONE, 2020, 15 (08):
  • [25] Effectiveness, cost, and safety of four regimens recommended by WHO for RR/MDR-TB treatment: a cohort study in Eastern China
    Gu, Pengcheng
    Lu, Peng
    Ding, Hui
    Liu, Qiao
    Ding, Xiaoyan
    Chen, Yongfa
    Zhu, Limei
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [26] Second (re-treatment) H-pylori therapy failure:: Should a third eradication regimen be tried?
    Gisbert, JP
    Boixeda, D
    Bermejo, E
    Arata, IG
    Rincón, MN
    Higes, MJ
    Arpa, MA
    de Argila, CM
    Plaza, AG
    GUT, 1998, 43 : A88 - A88
  • [27] Treatment of multidrug-resistant tuberculosis (MDR-TB) with modified shorter all-oral treatment regimen (mSTR) under operational research conditions in Belarus
    Skrahina, Alena
    Yatskevich, Natalia
    Hurevich, Henadz
    Grankov, Viatcheslav
    Klimuk, Dmitry
    Solodovnikova, Varvara
    Viatushka, Dmitry
    Skrahin, Aliaksandr
    Gurbanova, Elmira
    Dara, Masoud
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [28] Treatment Outcomes of the Standardized Shorter MDR-TB Regimen Under Programmatic Setting: A Retrospective Study from a Tertiary Care Centre, India
    Swathi, K. M. P.
    Somashekar, M.
    Chakraborty, A.
    Swapna, R.
    Akshata, J. S.
    Nagaraja, C.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2022, 18 (01) : 44 - 49
  • [29] Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
    Tiwari, Mani
    Patel, Mahendra
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [30] Adverse Drug Reactions in Patients put on Multi Drug Resistant Tuberculosis (MDR-TB) Treatment in Seven Districts of Central Gujarat
    Patel, Sangita Vashrambhai
    Bhikhubhai, Nimavat Kapil
    Patel, Alpesh Bhimabhai
    Shringarpure, Kalpita Samrat
    Mehta, Kedar Gautambhai
    Shukla, Lipy Krishnakumar
    JOURNAL OF YOUNG PHARMACISTS, 2015, 7 (04) : 425 - 431
1234